😷 Community-Acquired Pneumonia

Learning objective 1. Describe the pharmacokinetic and pharmacodynamic properties of antibiotics used for pneumonia.
Learning objective 2. Distinguish between various types of pneumonia using patient-specific factors, clinical manifestations, and diagnostic testing.
Learning objective 3. Use risk stratification tools to assess a patient’s risk with pneumonia and aid in determining setting of treatment.
Learning objective 4. List the likely causative pathogens for each type of pneumonia, including susceptibility profiles and patient risk factors for multidrug-resistant pathogens.
Learning objective 5. Given a patient with community-acquired pneumonia, design appropriate empiric therapy.
Learning objective 6. Recommend an appropriate duration of therapy for community-acquired pneumonia.